학술논문
Methods for Estimating Long-Term Outcomes for Trastuzumab Deruxtecan in HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies
Document Type
Article
Author
Source
In: Targeted Oncology . (Targeted Oncology, November 2022, 17(6):655-663)
Subject
Language
English
ISSN
1776260X
17762596
17762596